Free Trial

American Century Companies Inc. Has $21.18 Million Position in Nutrien Ltd. $NTR

Nutrien logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • American Century Companies Inc. raised its position in Nutrien by 16% in Q3 to 360,579 shares, a holding worth about $21.18 million (≈0.07% of the company).
  • Nutrien missed quarterly expectations with EPS of $0.83 vs. $0.87 expected and revenue of $5.12B vs. $5.26B expected (revenue was up 5.1% YoY); analysts’ consensus rating is "Hold" with an average price target of $72.82.
  • The company declared a quarterly dividend of $0.55 (annualized $2.20) yielding 2.9%, payable April 16, with a payout ratio of 46.78%.
  • MarketBeat previews the top five stocks to own by May 1st.

American Century Companies Inc. raised its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 16.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 360,579 shares of the company's stock after purchasing an additional 49,846 shares during the period. American Century Companies Inc. owned approximately 0.07% of Nutrien worth $21,175,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of NTR. Root Financial Partners LLC bought a new stake in shares of Nutrien in the 3rd quarter valued at $37,000. Huntington National Bank raised its position in shares of Nutrien by 72.6% during the second quarter. Huntington National Bank now owns 656 shares of the company's stock worth $38,000 after purchasing an additional 276 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company's stock worth $43,000 after purchasing an additional 219 shares during the period. Bessemer Group Inc. lifted its holdings in shares of Nutrien by 27.7% during the 3rd quarter. Bessemer Group Inc. now owns 937 shares of the company's stock valued at $55,000 after purchasing an additional 203 shares in the last quarter. Finally, AlphaCore Capital LLC bought a new position in shares of Nutrien during the 2nd quarter valued at about $56,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

NTR has been the subject of a number of research reports. Zacks Research cut Nutrien from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 2nd. TD Securities increased their price objective on shares of Nutrien from $80.00 to $81.00 and gave the stock a "buy" rating in a research report on Tuesday, February 17th. Royal Bank Of Canada boosted their price objective on shares of Nutrien from $75.00 to $80.00 and gave the company an "outperform" rating in a research report on Monday, February 23rd. BMO Capital Markets lifted their price target on Nutrien from $75.00 to $85.00 and gave the company an "outperform" rating in a research note on Friday, February 20th. Finally, Scotiabank upped their price objective on Nutrien from $63.00 to $70.00 and gave the stock a "sector perform" rating in a research report on Monday, February 2nd. Eight research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $72.82.

Check Out Our Latest Stock Report on Nutrien

Nutrien Price Performance

Shares of NTR opened at $75.85 on Tuesday. The company has a market cap of $36.49 billion, a price-to-earnings ratio of 16.28 and a beta of 0.70. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. The company's fifty day simple moving average is $68.74 and its 200 day simple moving average is $62.04. Nutrien Ltd. has a 1-year low of $45.78 and a 1-year high of $78.08.

Nutrien (NYSE:NTR - Get Free Report) last issued its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The firm had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The company's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the business posted $0.31 earnings per share. On average, research analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.20 annualized dividend and a yield of 2.9%. This is an increase from Nutrien's previous quarterly dividend of $0.55. Nutrien's payout ratio is currently 46.78%.

Nutrien Company Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines